CryoPort, Inc. CYRX
17.41
0.01
0.06%
as of 25 Sep
- Market cap
- $881.3M
- P/E
- 0.0×
Follow CYRX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (9.85%) | 17.64% | 16.98% | 14.73% |
+8 more TTM periods Free account |
|
| (5.93%) | 9.80% | 9.57% | 8.57% | ||
ROIC |
(8.79%) | (8.80%) | (8.26%) | (8.86%) | |
Return on Tangible Assets |
(13.60%) | 21.38% | 20.52% | 11.77% | |
Average Days of Receivables |
71.36 | 77.82 | 69.11 | 74.01 | |
Free Cash Flow per Share |
(0.42) | (0.53) | (0.56) | (0.70) | |
Free Cash Flow |
(21.35) | (26.21) | (28.08) | (35.18) | |
Capital Expenditures |
(29.32) | (25.71) | (19.50) | (20.20) | |
Piotroski F-Score |
4.00 | 5.00 | 5.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
0.74% | (0.05%) | (0.78%) | (1.34%) | |
Accounts Receivable Turnover |
5.34 | 5.43 | 6.01 | 4.39 | |
Accounts Payable Turnover |
6.37 | 6.58 | 5.97 | 4.67 | |
Inventory Turnover |
4.43 | 4.29 | 4.17 | 3.90 | |
Average Days of Payables |
60.10 | 60.21 | 59.90 | 55.48 | |
Days of Inventory on Hand |
79.55 | 82.17 | 90.89 | 93.21 | |
Tax Rate |
0.06 | 0.05 | 0.06 | 0.01 | |
Research and Development Expense of Revenue |
9.52% | 9.30% | 9.67% | 9.72% | |
Selling, General and Administrative Expense of Revenue |
58.80% | 59.33% | 58.36% | 60.19% | |
Share Based Compensation of Revenue |
5.23% | 5.32% | 6.26% | 7.56% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.18) | (0.01) | (0.12) | (0.24) | |
Depreciation/Fixed assets |
0.29 | 0.31 | 0.34 | 0.37 | |
Capex/Depreciation |
(1.09) | (0.93) | (0.67) | (0.66) | |
Revenue per Share |
3.70 | 3.67 | 3.52 | 3.44 | |
Operating CF per Share |
0.16 | (0.01) | (0.17) | (0.30) | |
Capex per Share |
(0.58) | (0.52) | (0.39) | (0.40) | |
Capex to Sales |
0.16 | 0.14 | 0.11 | 0.12 | |
Net Profit Margin |
(24.34%) | 39.22% | 39.90% | 36.75% |
Columns are period end dates